Comparative Pharmacology
Head-to-head clinical analysis: CLINIMIX 5 10 SULFITE FREE IN DEXTROSE 10 IN PLASTIC CONTAINER versus PERIKABIVEN IN PLASTIC CONTAINER.
Peer-Reviewed Evidence
Head-to-head clinical analysis: CLINIMIX 5 10 SULFITE FREE IN DEXTROSE 10 IN PLASTIC CONTAINER versus PERIKABIVEN IN PLASTIC CONTAINER.
CLINIMIX 5/10 SULFITE FREE IN DEXTROSE 10% IN PLASTIC CONTAINER vs PERIKABIVEN IN PLASTIC CONTAINER
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Provides essential amino acids and dextrose for parenteral nutrition; amino acids serve as substrates for protein synthesis, and dextrose supplies caloric energy to prevent catabolism and promote anabolism.
Perikabiven provides a balanced mixture of amino acids, electrolytes, dextrose, and lipids for parenteral nutrition. Amino acids serve as building blocks for protein synthesis, dextrose provides glucose for energy, and lipids supply essential fatty acids and a concentrated energy source. Electrolytes maintain osmotic balance and support biochemical reactions.
Intravenous administration as a source of calories and amino acids. Typical adult dose: 500-1000 mL per day, infused at a rate determined by the patient's metabolic needs and clinical condition. Rate not to exceed 100 mL/hour initially.
Intravenous administration: usual adult dose is 1.5 to 2.0 g amino acids per kg per day, corresponding to 25-30 mL/kg/day of Perikabiven, with a maximum infusion rate of 2.5 mL/kg/hour.
None Documented
None Documented
Amino acids: 4-6 hours; dextrose: 2-3 hours. Clinically, infusion rate clearance is rapid, with sustained effect only during continuous administration.
Amino acids: ~0.5-1 hour (rapid clearance due to metabolic incorporation and urinary elimination). Lipids: terminal elimination half-life of ~30 minutes to 1.5 hours for triglycerides, with longer half-life for essential fatty acids (days to weeks due to incorporation into cell membranes). Clinical context: rapid clearance from plasma with continuous infusion.
Renal: >95% as free amino acids and dextrose metabolites. Biliary/fecal: <5%.
Renal (primarily as ammonium and urea) and biliary (fecal loss of unabsorbed lipids). The amino acids, dextrose, and electrolytes are eliminated via renal excretion; lipids are metabolized and eliminated as CO2 and water. Approximately 20-30% of the lipid dose is excreted renally as metabolites, with <5% excreted unchanged.
Category C
Category C
Parenteral Nutrition
Parenteral Nutrition